Ocupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.
Research & Development Department Avizor, 28919 Leganés, Spain.
Biomolecules. 2021 Feb 24;11(3):340. doi: 10.3390/biom11030340.
Circadian rhythm and the molecules involved in it, such as melanopsin and melatonin, play an important role in the eye to regulate the homeostasis and even to treat some ocular conditions. As a result, many ocular pathologies like dry eye, corneal wound healing, cataracts, myopia, retinal diseases, and glaucoma are affected by this cycle. This review will summarize the current scientific literature about the influence of circadian patterns on the eye, focusing on its relationship with increased intraocular pressure (IOP) fluctuations and glaucoma. Regarding treatments, two ways should be studied: the first one, to analyze if some treatments could improve their effect on the ocular disease when their posology is established in function of circadian patterns, and the second one, to evaluate new drugs to treat eye pathologies related to the circadian rhythm, as it has been stated with melatonin or its analogs, that not only could be used as the main treatment but as coadjutant, improving the circadian pattern or its antioxidant and antiangiogenic properties.
昼夜节律及其中涉及的分子,如黑视蛋白和褪黑素,在眼睛中起着重要作用,可调节体内平衡,甚至可治疗某些眼部疾病。因此,许多眼部疾病,如干眼症、角膜创伤愈合、白内障、近视、视网膜疾病和青光眼,都受到这个周期的影响。这篇综述将总结关于昼夜节律模式对眼睛影响的当前科学文献,重点关注其与眼压(IOP)波动和青光眼的关系。关于治疗,有两种方法值得研究:第一种是分析某些治疗方法在根据昼夜节律模式确定其剂量时,是否可以改善其对眼部疾病的疗效;第二种是评估新的药物来治疗与昼夜节律相关的眼部疾病,如已经用褪黑素或其类似物进行了研究,褪黑素不仅可以作为主要治疗药物,还可以作为辅助药物,改善昼夜节律或其抗氧化和抗血管生成特性。